2013
DOI: 10.1016/j.carbon.2013.07.005
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the toxicity of graphene derivatives on cells of the lung luminal surface

Abstract: Graphene-based nanomaterials are expected to have a profound impact on a broad range of applications. However, studies devoted to investigating the putative adverse health effects of these nanomaterials are hugely underrepresented in the current scientific literature. We have investigated the in vitro short-term cellular toxicity associated with graphene derivatives (GD): graphene oxide and reduced graphene oxide. This study focused on the toxicity of GD on two cell types (i.e., epithelial cells and macrophage… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
48
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 94 publications
(53 citation statements)
references
References 62 publications
5
48
0
Order By: Relevance
“…The mild cytotoxicity of GO can be explained by the presence of GO nanosheets in phagoendosomes not causing any apparent adverse changes in the cellular morphology and ultrastructure (12). Some studies investigated graphene in the form of a film that can exhibit excellent biocompatibility with no viability inhibition of mammalian cells.…”
Section: Resultsmentioning
confidence: 98%
“…The mild cytotoxicity of GO can be explained by the presence of GO nanosheets in phagoendosomes not causing any apparent adverse changes in the cellular morphology and ultrastructure (12). Some studies investigated graphene in the form of a film that can exhibit excellent biocompatibility with no viability inhibition of mammalian cells.…”
Section: Resultsmentioning
confidence: 98%
“…Lately there has been public and government concern about the toxicity of nanomaterials and their related adverse health effects, such as pronounced pulmonary inflammation (Horváth et al, 2013; Karlsson et al, 2009; Oberdörster, 2005). Other examples include the smaller silver NPs causing a greater apoptotic effect against certain cell lines and 20 nm silica NPs exhibiting more toxicity than negatively-charged 100 nm silica NPs (Kim et al, 2012; Park et al, 2013; Sosenkova and Egorova, 2011).…”
Section: Overview Of Physicochemical Characteristicsmentioning
confidence: 99%
“…Although NPs with certain chemical compositions were reported to be more toxic compared to their larger counterparts of the same composition, a consensus on the increased toxicity and putative health risks of nanomaterials may not emerge due to the lack of obvious size-related change in toxicity in other NPs, e.g. titanium oxide and iron oxides (Buzea et al, 2007; Horváth et al, 2013; Karlsson et al, 2009; Park et al, 2007; Warheit et al, 2006). The relationship of size and/or shape to nanoparticle toxicity or nanomedicine efficacy has to be investigated on a case by case basis, because of the wide differences in the behavior of different nanomaterials.…”
Section: Overview Of Physicochemical Characteristicsmentioning
confidence: 99%
“…14,15 For example, GO and rGO treatments resulted in dose-dependent cell death in A549 cells and HUVEC cells, and the functionalization decreased cytotoxicity and cell death. 16,17 Cell death is a signal that reflects the toxicity of GBMs, [18][19][20] and this review focuses on the mechanisms of GBMsinduced PCD.…”
Section: Introductionmentioning
confidence: 99%